Wilson’s disease is a rare genetic condition in which your body cannot properly remove copper, causing it to build up to dangerous levels in your liver, brain, and other organs. It affects roughly 20 to 33 people per million worldwide and is typically diagnosed between ages 5 and 35, though it can appear later. With early treatment, most people with Wilson’s disease can manage the condition effectively and live full lives. Left untreated, it can cause severe liver damage, permanent neurological problems, and death.
How Copper Builds Up
Normally, your liver processes copper from the food you eat and excretes the excess into bile, which leaves your body through the digestive tract. In Wilson’s disease, mutations in a gene called ATP7B disrupt this process. The faulty gene produces a defective version of a protein responsible for transporting copper out of liver cells. Without a functioning transport system, copper accumulates inside the liver first, then spills into the bloodstream and deposits in other tissues, particularly the brain, eyes, and kidneys.
Wilson’s disease follows an autosomal recessive inheritance pattern, meaning you need to inherit one defective copy of ATP7B from each parent to develop it. People who carry only one copy are unaffected carriers. Because siblings of a diagnosed person have a 25% chance of also having the disease, genetic testing of first-degree relatives is strongly recommended once someone in the family is identified.
Liver Symptoms
The liver is almost always the first organ affected, since that’s where copper initially accumulates. Some people show no obvious symptoms early on, with the only clue being mildly abnormal liver enzyme levels found on routine blood work. Others develop signs of active hepatitis or progressive scarring (fibrosis), which can eventually advance to cirrhosis. At that stage, you might notice jaundice, abdominal swelling from fluid buildup, easy bruising, or fatigue.
In a smaller number of cases, Wilson’s disease announces itself dramatically through acute liver failure. This can happen suddenly, even in someone who had no prior signs of liver trouble. It’s a medical emergency that may require a liver transplant. One unusual lab pattern that often tips off doctors: the liver enzyme that normally rises during inflammation (alkaline phosphatase) stays low or normal, while bilirubin, a marker of red blood cell breakdown, runs high. That combination is uncommon in other liver diseases and serves as a diagnostic clue.
Neurological and Psychiatric Effects
About 40 to 50% of people with Wilson’s disease develop neurological symptoms by the time they’re diagnosed. Copper deposits in the brain cause a range of movement problems: tremors (often the first sign), difficulty with coordination, muscle stiffness resembling Parkinson’s disease, and involuntary twisting movements called dystonia. Speech may become slurred, and handwriting often deteriorates. These symptoms tend to worsen gradually if the disease goes unrecognized.
Psychiatric changes are even more common than movement disorders and frequently appear before anyone suspects Wilson’s disease. Studies report personality and behavioral changes in 46 to 71% of patients, with irritability, aggression, and impulsive or antisocial behavior being the most frequent. Depression and anxiety also occur. Because these symptoms overlap with common psychiatric conditions, Wilson’s disease is sometimes misdiagnosed for years, particularly in teenagers and young adults whose behavioral changes get attributed to normal adolescence or mental health disorders.
Kayser-Fleischer Rings
One of the most distinctive signs of Wilson’s disease is the Kayser-Fleischer ring, a brownish or greenish-gold ring visible around the outer edge of the cornea. These rings are caused by copper depositing in a thin membrane at the back of the cornea. They typically start at the top of the eye and gradually spread around the full circumference. The color can vary from golden-brown to greenish-yellow or even blue.
Kayser-Fleischer rings don’t affect your vision, and they’re often too subtle to see without a specialized eye exam using a slit lamp. Nearly 95% of patients with neurological symptoms have them, making the rings an extremely reliable diagnostic sign in that group. Among people whose Wilson’s disease primarily affects the liver, only about 50% show the rings. In children and asymptomatic patients, the figure drops further, to roughly 10 to 40%.
How It’s Diagnosed
No single test confirms Wilson’s disease on its own, so doctors use a combination of findings. The workup typically includes blood tests measuring ceruloplasmin (a copper-carrying protein that runs low in most patients), 24-hour urine copper collection (which runs high), a slit-lamp eye exam looking for Kayser-Fleischer rings, and sometimes liver biopsy to measure copper content directly. Genetic testing for ATP7B mutations can confirm a borderline case and is especially useful for screening family members.
A standardized scoring system called the Leipzig score helps doctors weigh all these results together. It assigns points for each finding, including ceruloplasmin levels, urine copper, the presence of Kayser-Fleischer rings, neurological symptoms, and liver copper levels. A total score of 4 or higher establishes a definitive diagnosis, while a score of 3 is considered “possible” and calls for additional testing. The scoring system exists because Wilson’s disease can mimic many other conditions, and individual test results sometimes fall in gray zones.
Treatment: Removing and Blocking Copper
Treatment for Wilson’s disease has two phases: an initial phase to remove accumulated copper, followed by lifelong maintenance therapy to keep copper levels from rising again.
The initial phase uses copper-chelating medications, which bind to copper in your body and help your kidneys excrete it in urine. Two chelators are commonly prescribed. The older one, penicillamine, is effective but carries a higher rate of side effects, including joint pain, skin rashes, and kidney problems, so it requires close monitoring. The newer alternative, trientine, is generally better tolerated, with the most common side effects being digestive issues, hair thinning, and mood changes. Adults typically take trientine in divided doses totaling 750 mg to 1,250 mg per day.
Once copper levels have dropped to a safe range, many patients transition to zinc acetate for maintenance. Zinc works through a completely different mechanism: it stimulates cells lining your gut to produce a protein that traps copper from food and prevents it from entering the bloodstream. The trapped copper leaves your body naturally when those intestinal cells shed. Zinc acetate can also be used as the primary treatment for people who can’t tolerate chelating drugs or who are diagnosed before symptoms appear.
For patients who present with acute liver failure or whose liver disease has progressed too far to respond to medication, liver transplant is the definitive treatment. Because the genetic defect resides in the liver, a transplant effectively cures the copper metabolism problem.
Foods High in Copper
Dietary changes alone aren’t enough to manage Wilson’s disease, but avoiding foods unusually high in copper helps reduce the burden on your body, particularly during the early treatment phase. The National Institute of Diabetes and Digestive and Kidney Diseases recommends limiting or avoiding:
- Shellfish (especially oysters, lobster, and crab)
- Liver and organ meats
- Mushrooms
- Nuts (cashews, almonds, pistachios, and others)
- Chocolate
Your doctor may also recommend testing your drinking water for copper content, since water that sits in copper pipes can absorb significant amounts. As treatment lowers your body’s copper stores over time, dietary restrictions may loosen, but most patients continue to avoid the highest-copper foods indefinitely.
Long-Term Outlook
Wilson’s disease requires lifelong treatment, but the prognosis for people who start therapy before irreversible organ damage has occurred is very good. Liver inflammation often improves significantly within months, and many neurological symptoms stabilize or partially reverse over one to three years of consistent treatment. People diagnosed and treated early can expect a normal or near-normal lifespan.
The biggest risk to long-term health is stopping medication. Because Wilson’s disease never goes away on its own, even a few months off treatment can allow copper to re-accumulate rapidly, sometimes triggering acute liver failure. Adherence to medication, regular monitoring of copper levels and liver function, and screening of siblings and children are the pillars of successful long-term management.